Glück Conviction Score™ ⓘ
SNDX
Syndax Pharmaceuticals Inc
Effektiv: Neutral
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
57,6
42 neu, 97 erhöht, 168,2M $ netto
Aktivist
23,9
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 20.93 | -12.8 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 19.45 | -6.1 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 18.78 | EMA50: 20.13 | |
| MACD-Histogramm | Bullisch | 10 % | 0.009 | Bullisch | |
| RSI(14) | Neutral | 10 % | 41.1 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 42.2 | Neutral | |
| ADX(14)+DI | Bärisch | 10 % | 26.6 | +DI: 14.5 / −DI: 27.0 | |
| Z-Score(60) | Neutral | 5 % | -1.33 | In Range | |
| 52W-Position | Neutral | 5 % | 58.0 % | Hoch 25.15 / Tief 8.73 | |
| Bollinger(20,2σ) | Neutral | 5 % | 35.1 % | Upper 20.87 / Mid 18.85 / Lower 16.83 | |
| LinReg-Slope(60) | Bärisch | 10 % | -0.1278 | R²=0.86 / annualisiert -150.3 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | Botwood Nicholas A.J. | Officer, Head of R&D, CMO | Open Market Sale | -31.235 | 18,14 | -566.602,90 | -144,1% | |
| 2026-06-11 | Botwood Nicholas A.J. | Officer, Head of R&D, CMO | Open Market Sale | -34.280 | 18,00 | -617.040,00 | -157,0% | |
| 2026-06-01 | Metzger Michael A | Director, Officer, Chief Executive Officer | Open Market Sale | -6.847 | 18,99 | -130.024,53 | -33,1% | |
| 2026-06-01 | Goldan Keith A. | Officer, Chief Financial Officer | Open Market Sale | -1.177 | 18,99 | -22.351,23 | -5,7% | |
| 2026-02-09 | Metzger Michael A | Director, Officer, Chief Executive Officer | Open Market Sale | -17.159 | 21,03 | -360.819,45 | -91,8% | |
| 2026-02-09 | Goldan Keith A. | Officer, Chief Financial Officer | Open Market Sale | -3.410 | 21,03 | -71.705,48 | -18,2% | |
| 2026-02-06 | Metzger Michael A | Director, Officer, Chief Executive Officer | Open Market Sale | -7.412 | 20,62 | -152.835,44 | -38,9% | |
| 2026-02-06 | Goldan Keith A. | Officer, Chief Financial Officer | Open Market Sale | -2.082 | 20,62 | -42.930,84 | -10,9% | |
| 2025-09-08 | Metzger Michael A | Director, Officer, Chief Executive Officer | Open Market Sale | -157.307 | 16,41 | -2.582.021,37 | -656,8% | |
| 2025-08-18 | Podlesak Dennis | Director | Open Market Sale | -19.200 | 15,84 | -304.170,24 | -77,4% | |
| 2025-08-15 | Podlesak Dennis | Director | Open Market Sale | -19.200 | 15,54 | -298.408,32 | -75,9% | |
| 2025-08-14 | Podlesak Dennis | Director | Open Market Sale | -19.200 | 14,19 | -272.520,96 | -69,3% | |
| 2025-07-16 | Metzger Michael A | Director, Officer, Chief Executive Officer | Open Market Sale | -7.534 | 9,29 | -69.953,19 | -17,8% | |
| 2025-07-16 | Goldan Keith A. | Officer, Chief Financial Officer | Open Market Sale | -1.296 | 9,29 | -12.033,36 | -3,1% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 8.254.426 | 8.239.002 | 15.424 | 192.823.390 | Aufgestockt | +0,2% | |
| Kynam Capital Management, LP | 8.050.959 | 8.050.959 | 0 | 188.070.402 | Unverändert | 0,0% | |
| VANGUARD GROUP INC | 6.230.334 | 0 | 6.230.334 | 130.899.317 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 4.996.787 | 5.695.375 | -698.588 | 116.724.944 | Reduziert | -12,3% | |
| STATE STREET CORP | 4.430.076 | 4.596.552 | -166.476 | 103.486.575 | Reduziert | -3,6% | |
| BANK OF AMERICA CORP /DE/ | 4.249.836 | 4.710.746 | -460.910 | 99.276.168 | Reduziert | -9,8% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.822.579 | 0 | 3.822.579 | 89.295.445 | Neu | +100,0% | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3.779.900 | 0 | 3.779.900 | 88.298.464 | Neu | +100,0% | |
| Eversept Partners, LP | 2.885.622 | 3.314.408 | -428.786 | 67.408.130 | Reduziert | -12,9% | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2.500.000 | 2.350.000 | 150.000 | 58.400.000 | Aufgestockt | +6,4% | |
| Hood River Capital Management LLC | 2.354.285 | 2.316.553 | 37.732 | 54.996.098 | Aufgestockt | +1,6% | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.157.058 | 2.090.932 | 66.126 | 50.399.089 | Aufgestockt | +3,2% | |
| FRANKLIN RESOURCES INC | 2.150.079 | 2.421.666 | -271.587 | 50.225.842 | Reduziert | -11,2% | |
| Point72 Asset Management, L.P. | 1.985.547 | 4.882.053 | -2.896.506 | 46.382.378 | Reduziert | -59,3% | |
| Elmind Capital, LP | 1.855.000 | 1.855.000 | 0 | 43.332.800 | Unverändert | 0,0% | |
| BNP Paribas Asset Management Holding S.A. | 1.732.541 | 1.375.681 | 356.860 | 40.472.158 | Aufgestockt | +25,9% | |
| Soleus Capital Management, L.P. | 1.726.908 | 2.247.110 | -520.202 | 40.340.571 | Reduziert | -23,1% | |
| D. E. Shaw & Co., Inc. | 1.601.896 | 1.219.609 | 382.287 | 37.420.290 | Aufgestockt | +31,3% | |
| TWO SIGMA INVESTMENTS, LP | 1.579.596 | 1.146.936 | 432.660 | 36.899.363 | Aufgestockt | +37,7% | |
| Nuveen, LLC | 1.494.645 | 1.483.002 | 11.643 | 34.914.908 | Aufgestockt | +0,8% | |
| MPM BioImpact LLC | 1.340.733 | 1.337.702 | 3.031 | 31.319.523 | Aufgestockt | +0,2% | |
| Aisling Capital Management LP | 1.316.806 | 1.316.806 | 0 | 30.760.588 | Unverändert | 0,0% | |
| Woodline Partners LP | 1.250.760 | 1.250.668 | 92 | 29.217.754 | Aufgestockt | 0,0% | |
| STEMPOINT CAPITAL LP | 1.365.743 | 1.339.379 | 26.364 | 28.489.756 | Aufgestockt | +2,0% | |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.208.987 | 642.899 | 566.088 | 28.241.936 | Aufgestockt | +88,1% | |
| UBS Group AG | 1.153.662 | 788.519 | 365.143 | 26.949.545 | Aufgestockt | +46,3% | |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.238.196 | 0 | 1.238.196 | 26.014.313 | Neu | +100,0% | |
| Catalio Capital Management, LP | 1.043.670 | 1.196.807 | -153.137 | 24.380.131 | Reduziert | -12,8% | |
| Ensign Peak Advisors, Inc | 990.969 | 1.598.544 | -607.575 | 23.149.036 | Reduziert | -38,0% | |
| AQR CAPITAL MANAGEMENT LLC | 980.314 | 925.974 | 54.340 | 22.900.136 | Aufgestockt | +5,9% | |
| ORBIMED ADVISORS LLC | 962.300 | 0 | 962.300 | 22.479.328 | Neu | +100,0% | |
| Candriam S.C.A. | 925.332 | 925.332 | 0 | 21.615.756 | Unverändert | 0,0% | |
| Parkman Healthcare Partners LLC | 901.511 | 574.023 | 327.488 | 21.059.297 | Aufgestockt | +57,1% | |
| MORGAN STANLEY | 893.933 | 1.075.501 | -181.568 | 20.882.275 | Reduziert | -16,9% | |
| Palo Alto Investors LP | 864.986 | 794.507 | 70.479 | 20.206.073 | Aufgestockt | +8,9% | |
| Prosight Management, LP | 770.000 | 665.000 | 105.000 | 17.987.200 | Aufgestockt | +15,8% | |
| CITADEL ADVISORS LLC | 767.542 | 368.303 | 399.239 | 17.929.781 | Aufgestockt | +108,4% | |
| NORTHERN TRUST CORP | 755.719 | 728.921 | 26.798 | 17.653.596 | Aufgestockt | +3,7% | |
| SPHERA FUNDS MANAGEMENT LTD. | 724.563 | 762.563 | -38.000 | 16.925.792 | Reduziert | -5,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 715.153 | 727.424 | -12.271 | 16.705.974 | Reduziert | -1,7% | |
| Trails Edge Capital Partners, LP | 701.821 | 0 | 701.821 | 16.394.539 | Neu | +100,0% | |
| TWO SIGMA ADVISERS, LP | 632.752 | 0 | 632.752 | 13.294.120 | Neu | +100,0% | |
| APIS CAPITAL ADVISORS, LLC | 550.000 | 724.000 | -174.000 | 12.848.000 | Reduziert | -24,0% | |
| ExodusPoint Capital Management, LP | 554.761 | 0 | 554.761 | 11.655.529 | Neu | +100,0% | |
| Caption Management, LLC | 554.500 | 0 | 554.500 | 11.650.045 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 498.200 | 544.800 | -46.600 | 11.637.952 | Reduziert | -8,6% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 472.121 | 714.753 | -242.632 | 11.028.747 | Reduziert | -33,9% | |
| Knott David M Jr | 422.000 | 415.000 | 7.000 | 9.857.920 | Aufgestockt | +1,7% | |
| Walleye Capital LLC | 402.073 | 51.805 | 350.268 | 9.392.425 | Aufgestockt | +676,1% | |
| JANE STREET GROUP, LLC | 385.031 | 828.820 | -443.789 | 8.994.325 | Reduziert | -53,5% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.254.426 | 8.239.002 | +0,2% | 192.823.390 | 8,64 |
| Kynam Capital Management, LP | 8.050.959 | 8.050.959 | 0,0% | 188.070.402 | 8,43 |
| GOLDMAN SACHS GROUP INC | 4.996.787 | 5.695.375 | -12,3% | 116.724.944 | 5,23 |
| STATE STREET CORP | 4.430.076 | 4.596.552 | -3,6% | 103.486.575 | 4,64 |
| BANK OF AMERICA CORP /DE/ | 4.249.836 | 4.710.746 | -9,8% | 99.276.168 | 4,45 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.822.579 | 0 | +100,0% | 89.295.445 | 4,00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3.779.900 | 0 | +100,0% | 88.298.464 | 3,96 |
| Eversept Partners, LP | 2.885.622 | 3.314.408 | -12,9% | 67.408.130 | 3,02 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2.500.000 | 2.350.000 | +6,4% | 58.400.000 | 2,62 |
| Hood River Capital Management LLC | 2.354.285 | 2.316.553 | +1,6% | 54.996.098 | 2,47 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.157.058 | 2.090.932 | +3,2% | 50.399.089 | 2,26 |
| FRANKLIN RESOURCES INC | 2.150.079 | 2.421.666 | -11,2% | 50.225.842 | 2,25 |
| Point72 Asset Management, L.P. | 1.985.547 | 4.882.053 | -59,3% | 46.382.378 | 2,08 |
| Elmind Capital, LP | 1.855.000 | 1.855.000 | 0,0% | 43.332.800 | 1,94 |
| BNP Paribas Asset Management Holding S.A. | 1.732.541 | 1.375.681 | +25,9% | 40.472.158 | 1,81 |
| Soleus Capital Management, L.P. | 1.726.908 | 2.247.110 | -23,1% | 40.340.571 | 1,81 |
| D. E. Shaw & Co., Inc. | 1.601.896 | 1.219.609 | +31,3% | 37.420.290 | 1,68 |
| TWO SIGMA INVESTMENTS, LP | 1.579.596 | 1.146.936 | +37,7% | 36.899.363 | 1,65 |
| Nuveen, LLC | 1.494.645 | 1.483.002 | +0,8% | 34.914.908 | 1,57 |
| MPM BioImpact LLC | 1.340.733 | 1.337.702 | +0,2% | 31.319.523 | 1,40 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 246 | 106,4 | 2.449 |
| 31.12.2025 | ✓ | 230 | 108,8 | 2.230 |
| 30.09.2025 | ✓ | 235 | 108,9 | 1.631 |
| 30.06.2025 | ✓ | 216 | 106,2 | 960 |
| 31.03.2025 | ✓ | 221 | 144,0 | 1.458 |
| 31.12.2024 | ✓ | 216 | 106,0 | 1.363 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Hood River Capital Management LLC | 2.316.553 | 48.670.779 |
| Elmind Capital, LP | 1.855.000 | 38.973.550 |
| Pale Fire Capital SE | 284.460 | 5.976.505 |
| Pinnacle Financial Partners, Inc. | 206.601 | 4.340.687 |
| Integral Health Asset Management, LLC | 200.000 | 4.202.000 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 180.000 | 3.782.000 |
| Atom Investors LP | 141.666 | 2.976.403 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 137.629 | 2.891.585 |
| Voss Capital, LP | 125.000 | 2.626.250 |
| Ishara Investments LP | 100.000 | 2.101.000 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| VANGUARD GROUP INC | 6.230.334 | 1.091.717 | +21.2 % | 130.899.317 |
| BANK OF AMERICA CORP /DE/ | 4.710.746 | 1.012.993 | +27.4 % | 98.972.773 |
| Ensign Peak Advisors, Inc | 1.598.544 | 789.480 | +97.6 % | 33.585.409 |
| STATE STREET CORP | 4.596.552 | 743.003 | +19.3 % | 96.573.558 |
| Point72 Asset Management, L.P. | 4.882.053 | 627.006 | +14.7 % | 102.571.934 |
| ExodusPoint Capital Management, LP | 554.761 | 482.297 | +665.6 % | 11.655.529 |
| TWO SIGMA INVESTMENTS, LP | 1.146.936 | 434.277 | +60.9 % | 24.097.125 |
| Brevan Howard Capital Management LP | 515.129 | 390.554 | +313.5 % | 10.822.861 |
| SPHERA FUNDS MANAGEMENT LTD. | 762.563 | 374.847 | +96.7 % | 16.021.449 |
| AQR CAPITAL MANAGEMENT LLC | 925.974 | 367.898 | +65.9 % | 19.454.713 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Assenagon Asset Management S.A. | 41.737 | -1.742.402 | -97.7 % | 876.894 |
| UBS Group AG | 788.519 | -958.294 | -54.9 % | 16.566.784 |
| Qube Research & Technologies Ltd | 688.137 | -956.707 | -58.2 % | 14.457.758 |
| MILLENNIUM MANAGEMENT LLC | 101.937 | -944.519 | -90.3 % | 2.141.696 |
| BNP PARIBAS FINANCIAL MARKETS | 14.228 | -585.643 | -97.6 % | 298.930 |
| Kynam Capital Management, LP | 8.050.959 | -469.041 | -5.5 % | 169.150.649 |
| Catalio Capital Management, LP | 1.196.807 | -417.910 | -25.9 % | 25.144.915 |
| BlackRock, Inc. | 8.239.002 | -386.242 | -4.5 % | 173.101.429 |
| CITADEL ADVISORS LLC | 368.303 | -354.665 | -49.1 % | 7.738.046 |
| Prosight Management, LP | 665.000 | -338.400 | -33.7 % | 13.971.650 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 15.05.2026 | Steven A. Cohen | Passiv (13G/A) | 2,30 % | 1.985.547 | -2,70 pp | |
| 15.05.2026 | Point72 Capital Advisors, Inc. | Passiv (13G/A) | 2,30 % | 1.985.547 | -2,70 pp | |
| 15.05.2026 | Point72 Asset Management, L.P. | Passiv (13G/A) | 2,30 % | 1.985.547 | -2,70 pp | |
| 30.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,05 % | 4.457.143 | Neu | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -7,16 pp | |
| 09.02.2026 | STATE STREET CORPORATION | Passiv (13G) | 5,30 % | 4.596.552 | +0,90 pp | |
| 30.01.2026 | The Vanguard Group | Passiv (13G/A) | 7,16 % | 6.230.334 | +2,05 pp | |
| 18.08.2025 | Point72 Asset Management, L.P. | Passiv (13G) | 5,00 % | 4.327.952 | +2,30 pp | |
| 18.08.2025 | Steven A. Cohen | Passiv (13G) | 5,00 % | 4.327.952 | +2,30 pp | |
| 18.08.2025 | Point72 Capital Advisors, Inc. | Passiv (13G) | 5,00 % | 4.327.952 | +2,30 pp | |
| 14.08.2025 | Point72 Capital Advisors, Inc. | Passiv (13G/A) | 2,70 % | 2.307.824 | -2,30 pp | |
| 14.08.2025 | Point72 Asset Management, L.P. | Passiv (13G/A) | 2,70 % | 2.307.824 | -2,30 pp | |
| 14.08.2025 | Steven A. Cohen | Passiv (13G/A) | 2,70 % | 2.307.824 | -2,30 pp | |
| 13.08.2025 | THE GOLDMAN SACHS GROUP, INC. | Passiv (13G/A) | 6,50 % | 5.581.828 | +1,30 pp | |
| 13.08.2025 | GOLDMAN SACHS & CO. LLC | Passiv (13G/A) | 6,50 % | 5.581.828 | +1,30 pp | |
| 09.05.2025 | THE GOLDMAN SACHS GROUP, INC. | Passiv (13G/A) | 5,20 % | 4.510.669 | -1,80 pp | |
| 09.05.2025 | GOLDMAN SACHS & CO. LLC | Passiv (13G/A) | 5,20 % | 4.510.669 | -1,80 pp | |
| 07.05.2025 | Morgan Stanley | Passiv (13G/A) | 2,40 % | 2.040.013 | -3,90 pp | |
| 07.05.2025 | Morgan Stanley & Co. LLC | Passiv (13G/A) | 0,20 % | 213.174 | -5,70 pp | |
| 17.04.2025 | BlackRock, Inc. | Passiv (13G/A) | 7,80 % | 6.744.049 | Neu | |
| 07.03.2025 | Wellington Group Holdings LLP | Passiv (13G/A) | 0,00 % | 35.681 | -5,86 pp | |
| 07.03.2025 | Wellington Investment Advisors Holdings LLP | Passiv (13G/A) | 0,00 % | 35.681 | -5,86 pp | |
| 07.03.2025 | Wellington Management Group LLP | Passiv (13G/A) | 0,00 % | 35.681 | -5,86 pp | |
| 14.02.2025 | Kynam Capital Management, LP | Passiv (13G/A) | 9,98 % | 8.520.000 | +3,31 pp | |
| 14.02.2025 | Kynam Capital Management GP, LLC | Passiv (13G/A) | 9,98 % | 8.520.000 | +3,31 pp | |
| 14.02.2025 | Yue Tang | Passiv (13G/A) | 9,98 % | 8.520.000 | +3,31 pp | |
| 12.02.2025 | THE GOLDMAN SACHS GROUP, INC. | Passiv (13G) | 7,00 % | 5.953.465 | Neu | |
| 12.02.2025 | GOLDMAN SACHS & CO. LLC | Passiv (13G) | 7,00 % | 5.953.465 | Neu | |
| 05.02.2025 | Morgan Stanley | Passiv (13G) | 6,30 % | 5.362.169 | Neu | |
| 05.02.2025 | Morgan Stanley & Co. LLC | Passiv (13G) | 5,90 % | 5.055.451 | Neu | |
| 22.01.2025 | Point72 Capital Advisors, Inc. | Passiv (13G) | 5,00 % | 4.277.847 | +1,70 pp | |
| 22.01.2025 | Point72 Asset Management, L.P. | Passiv (13G) | 5,00 % | 4.277.847 | +1,70 pp | |
| 22.01.2025 | Steven A. Cohen | Passiv (13G) | 5,00 % | 4.277.847 | +1,70 pp | |
| 06.12.2024 | . BlackRock, Inc. | Passiv (13G/A) | 10,30 % | 8.787.650 | +0,60 pp | |
| 08.11.2024 | . BlackRock, Inc. | Passiv (13G/A) | 9,70 % | 8.239.080 | 0,00 pp | |
| 08.11.2024 | Wellington Management Company LLP | Passiv (13G/A) | 5,70 % | 4.848.463 | -3,02 pp | |
| 08.11.2024 | Wellington Management Group LLP | Passiv (13G/A) | 5,86 % | 4.985.976 | -3,08 pp | |
| 08.11.2024 | Wellington Group Holdings LLP | Passiv (13G/A) | 5,86 % | 4.985.976 | -3,08 pp | |
| 08.11.2024 | Wellington Investment Advisors Holdings LLP | Passiv (13G/A) | 5,86 % | 4.985.976 | -3,08 pp | |
| 21.10.2024 | . BlackRock, Inc. | Passiv (13G/A) | 9,70 % | 8.239.080 | +1,40 pp |
Stammdaten
Syndax Pharmaceuticals, Inc., ein Biopharmaunternehmen in klinischer Phase, entwickelt Therapien zur Behandlung von Krebs. Seine führenden Produktkandidaten sind SNDX-5613, das sich in einer Phase-1/2-klinischen Studie zur Bekämpfung der Bindungswechselwirkung von Menin mit dem Mixed-Lineage-Leukemia-1-Protein zur Behandlung von MLL-rearrangierten (MLLr) und Nukleophosmin-1-Mutanten-Akuter-Myeloischer-Leukämie (NPM1c AML) befindet, und SNDX-6352 oder Axatilimab, ein monoklonaler Antikörper, der den Colony-Stimulating-Factor-1 oder CSF-1-Rezeptor blockiert, zur Behandlung von Patienten mit chronischer Transplantat-gegen-Wirt-Erkrankung (cGVHD). Das Unternehmen entwickelt auch Entinostat. Es verfügt ferner über eine Forschungs- und Entwicklungskooperationsvereinbarung mit dem National Cancer Institute; eine klinische Versuchsvereinbarung mit der Eastern Cooperative Oncology Group; und eine Lizenzvereinbarung mit Kyowa Hakko Kirin Co., Ltd. Syndax Pharmaceuticals, Inc. wurde 2005 gegründet und hat seinen Sitz in Waltham, Massachusetts.Massachusetts.
Unternehmen & Branche
| Name | Syndax Pharmaceuticals Inc |
|---|---|
| Ticker | SNDX |
| CIK | 0001395937 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 87164f105 |
|---|---|
| ISIN | US87164F1057 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,57 Mrd. USD |
| Beta | 0,40 |
Bewertung
| KBV (P/B) | 24,31 vs. 2,95 (2021) ▲ |
|---|---|
| KUV (P/S) | 9,12 vs. 8,61 (2021) ▲ |
| FCF-Rendite | -20,6 % vs. 2,4 % (2021) ▼ |
Qualität & Bilanz
| Operative Marge | -158,4 % vs. 18,8 % (2021) ▼ |
|---|---|
| Nettomarge | -165,6 % vs. 17,8 % (2021) ▼ |
| ROIC | -441,6 % vs. 6,1 % (2021) ▼ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 2,95 | 3,71 | 3,31 | 3,93 | 28,41 | |
| KUV (P/S) | 8,61 | – | – | 47,84 | 10,65 | |
| FCF-Rendite | 2,4 % | -7,7 % | -8,8 % | -24,3 % | -17,6 % | |
| Qualität & Bilanz | ||||||
| Operative Marge | 18,8 % | – | – | -1.434,4 % | -158,4 % | |
| Nettomarge | 17,8 % | – | – | -1.346,1 % | -165,6 % | |
| ROIC | 6,1 % | -31,9 % | -37,7 % | -50,3 % | -441,6 % | |
| Zinsdeckungsgrad | 13,8 | -48,4 | – | – | – | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 64.864.000 | -42.673.000 | -0,48 | 472.668.000 | 41.622.000 |
| 2025-12-31 | 10-K | 172.352.000 | -285.422.000 | -3,29 | 529.706.000 | 64.630.000 |
| 2025-09-30 | 10-Q | 45.871.000 | -60.715.000 | -0,70 | 551.792.000 | 115.430.000 |
| 2025-06-30 | 10-Q | 37.958.000 | -71.847.000 | -0,83 | 596.149.000 | 157.424.000 |
| 2025-03-31 | 10-Q | 20.042.000 | -84.846.000 | -0,98 | 640.707.000 | 215.059.000 |
| 2024-12-31 | 10-K | 23.680.000 | -318.758.000 | -3,72 | 724.816.000 | 288.124.000 |
| 2024-09-30 | 10-Q | 12.500.000 | -84.126.000 | -0,98 | 425.811.000 | 366.432.000 |
| 2024-06-30 | 10-Q | 3.500.000 | -68.063.000 | -0,80 | 476.947.000 | 434.338.000 |
| 2024-03-31 | 10-Q | 0 | -72.400.000 | -0,85 | 543.028.000 | 491.889.000 |
| 2023-12-31 | 10-K | 0 | -209.360.000 | -2,98 | 612.880.000 | 554.196.000 |
| 2023-09-30 | 10-Q | 0 | -51.146.000 | -0,73 | 399.224.000 | 359.186.000 |
| 2023-06-30 | 10-Q | 0 | -44.615.000 | -0,64 | 431.340.000 | 400.041.000 |
| 2023-03-31 | 10-Q | -41.126.000 | -0,59 | 459.826.000 | 435.505.000 | |
| 2022-12-31 | 10-K | 0 | -149.338.000 | -2,46 | 497.236.000 | 467.449.000 |
| 2022-09-30 | 10-Q | -35.403.000 | -0,58 | 359.687.000 | 338.102.000 | |
| 2022-06-30 | 10-Q | -37.572.000 | -0,62 | 406.437.000 | 361.940.000 | |
| 2022-03-31 | 10-Q | -37.169.000 | -0,63 | 422.222.000 | 374.549.000 | |
| 2021-12-31 | 10-K | 139.709.000 | 24.926.000 | 0,46 | 449.657.000 | 408.368.000 |
| 2021-09-30 | 10-Q | 12.375.000 | -20.639.000 | -0,40 | 239.503.000 | 199.004.000 |
| 2021-06-30 | 10-Q | 379.000 | -22.910.000 | -0,44 | 263.059.000 | 214.563.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | Anteil | Δ | Trend |
|---|---|---|---|---|---|
| Net Product Revenues | 124,8 Mio. | 7,7 Mio. | 72,4 % | +1525,6% | |
| Collaboration Revenue | 42,4 Mio. | – | 24,6 % | Neu | |
| Milestone Revenue | 5,1 Mio. | 16,0 Mio. | 3,0 % | -67,9% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 30.04.2026 | 64,9 Mio. USD | -0,48 |
| Q3 2025 | 30.09.2025 | 03.11.2025 | 45,9 Mio. USD | -0,70 |
| Q2 2025 | 30.06.2025 | 03.11.2025 | 38,0 Mio. USD | -0,83 |
| Q1 2025 | 31.03.2025 | 30.04.2026 | 20,0 Mio. USD | -0,98 |
| Q3 2024 | 30.09.2024 | 03.11.2025 | 12,5 Mio. USD | -0,98 |
| Q2 2024 | 30.06.2024 | 03.11.2025 | 3,5 Mio. USD | -0,80 |
| Q1 2024 | 31.03.2024 | 03.11.2025 | 0 USD | -0,85 |
| Q3 2023 | 30.09.2023 | 05.11.2024 | 0 USD | -0,73 |
| Q2 2023 | 30.06.2023 | 05.11.2024 | 0 USD | -0,64 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 30.04.2026 | 10-Q | 31.03.2026 | 30 Tage | SEC » |
| 26.02.2026 | 10-K | 31.12.2025 | 57 Tage | SEC » |
| 03.11.2025 | 10-Q | 30.09.2025 | 34 Tage | SEC » |
| 04.08.2025 | 10-Q | 30.06.2025 | 35 Tage | SEC » |
| 05.05.2025 | 10-Q | 31.03.2025 | 35 Tage | SEC » |
| 03.03.2025 | 10-K | 31.12.2024 | 62 Tage | SEC » |
| 05.11.2024 | 10-Q | 30.09.2024 | 36 Tage | SEC » |
| 01.08.2024 | 10-Q | 30.06.2024 | 32 Tage | SEC » |
| 08.05.2024 | 10-Q | 31.03.2024 | 38 Tage | SEC » |
| 27.02.2024 | 10-K | 31.12.2023 | 58 Tage | SEC » |
| 02.11.2023 | 10-Q | 30.09.2023 | 33 Tage | SEC » |
| 03.08.2023 | 10-Q | 30.06.2023 | 34 Tage | SEC » |
| 08.05.2023 | 10-Q | 31.03.2023 | 38 Tage | SEC » |
| 28.02.2023 | 10-K | 31.12.2022 | 59 Tage | SEC » |
| 03.11.2022 | 10-Q | 30.09.2022 | 34 Tage | SEC » |
| 08.08.2022 | 10-Q | 30.06.2022 | 39 Tage | SEC » |
| 09.05.2022 | 10-Q | 31.03.2022 | 39 Tage | SEC » |
| 01.03.2022 | 10-K | 31.12.2021 | 60 Tage | SEC » |
| 15.11.2021 | 10-Q | 30.09.2021 | 46 Tage | SEC » |
| 09.08.2021 | 10-Q | 30.06.2021 | 40 Tage | SEC » |
| 11.05.2021 | 10-Q | 31.03.2021 | 41 Tage | SEC » |
| 30.04.2021 | 10-K/A | 31.12.2020 | 120 Tage | SEC » |
| 12.03.2021 | 10-K | 31.12.2020 | 71 Tage | SEC » |
| 05.11.2020 | 10-Q | 30.09.2020 | 36 Tage | SEC » |
| 06.08.2020 | 10-Q | 30.06.2020 | 37 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (10.06.2026)
HOCH Abgang Schlüsselpersonen (10.06.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 10.06.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 26.06.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 16.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 20.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | (a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 15.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 3(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 18.03.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 3(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 08.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | by specific reference in such filing. Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 30.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 08.02.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 05.12.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 20.02.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |